S. 2426 Congress 119 session
Equitable Community Access to Pharmacist Services Act
Equitable Community Access to Pharmacist Services Act This bill provides for permanent coverage under Medicare of certain pharmacist services. Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
In committee — last recorded action July 24, 2025
Read twice and referred to the Committee on Finance. (text: CR S4701)
Passage likelihood
6% Much lower than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 4% of introduced federal bills are enacted.
- Current stage Referred to committee.
- Cosponsors 31 cosponsors.
- Bipartisan cosponsorship Cosponsors come from 2 parties.
- Days without action No recorded action in 397 days.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Read twice and referred to the Committee on Finance. (text: CR S4701)
- Introduced in Senate